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Background: The appropriateness of cataract surgery procedures has been questioned, the suggestion being that
the surgery is sometimes undertaken too early in the disease progression. Our three study questions were: What is
the level of visual impairment in patients scheduled for cataract surgery? What is the improvement following
surgery? Given the thresholds for a minimal detectable change (MDC) and a minimal clinically important difference
(MCID), do gains in visual function reach the MDC and MCID thresholds?
Methods: The sample included a prospective cohort of cataract surgery patients from four Fraser Health Authority
ophthalmologists. Visual function (VF-14) was assessed pre-operatively and at seven weeks post-operatively. Two
groups from this cohort were included in this analysis: ‘all first eyes’ (cataract extraction on first eye) and ‘both eyes’
(cataract removed from both eyes). Descriptive statistics, change scores for VF-14 for each eye group and
proportion of patients who reach the MDC and MCID are reported.
Results: One hundred and forty-two patients are included in the ‘all first eyes’ analyses and 55 in the ‘both eyes’
analyses. The mean pre-operative VF-14 score for the ‘all first eyes‘ group was 86.7 (on a 0–100 scale where 100 is full
visual function). The mean change in VF-14 for the ‘both eyes‘ group was 7.5. Twenty-three percent of patients
achieved improvements in visual function beyond the MCID threshold and 35% saw improvement beyond the MDC.
Conclusions: Neither threshold level for MDC or MCID for the VF-14 scale was achieved for a majority of patients.
A plausible explanation for this is the very high levels of pre-operative visual functioning.
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The development of age-related cataracts is an inevitable
part of ageing for many people and without effective
treatment it is one of the leading causes of blindness
worldwide [1]. The widely acknowledged standard of
care is cataract extraction, typically performed first in
the lowest functioning eye. Compelling research evi-
dence supports the efficacy and cost-effectiveness of
cataract extraction when performed in patients with
poor baseline visual acuity [2-4]. Hence, it is not surpris-
ing that cataract removal, a 19-minute ambulatory sur-
gery [5], is one of the most frequently performed
surgical procedures in the developed world [6].* Correspondence: Jennifer.davis@ubc.ca
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reproduction in any medium, provided the orHowever, the appropriateness of some cataract surgery
procedures has been questioned repeatedly, the sugges-
tion being that the surgery is sometimes undertaken at
too early a stage in the disease progression [7-9]. This
concern is based on reports of wide variations in post-
surgery outcomes and estimates of health gain [10]. Low
thresholds for cataract surgery in a Canadian setting were
demonstrated by Wright et al. in their Regional Evalu-
ation of Surgical Indications and Outcomes (RESIO)
study [11]. Thirty-two percent of RESIO patients sched-
uled for first cataract surgery had a pre-operative visual
function score of 90 or higher on the visual functioning
VF-14 scale (where 100 is full visual functioning). With
such high levels of visual function, the scope for
improvements in functioning is very limited. Therefore,
some 10 years after publication of the RESIO data, we re-
visit cataract surgery thresholds and outcomes in
Canada. Black and colleagues conducted a study in thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cataract surgery in England [12]. Although the notable
reduction in the visual function threshold for cataract
surgery was due to improvements in the provision of
cataract surgery, methodological challenges in measuring
post surgical outcomes rendered it impossible to con-
clude whether overutilization was indeed occurring [12].
To our knowledge, there is no such recent work con-
ducted in Canada. As such, this study seeks to explore
visual impairment thresholds for cataract surgery and
levels of improvement seen following cataract surgery in
Canada. Further, we explore factors relating to variation
in thresholds and outcomes relating to cataract surgery
such as the unit of analysis.
This paper reports data collected for an evaluation of
cataract surgery outcomes conducted at Fraser Health
Authority ophthalmology practices in British Columbia
between April 2009 and March 2010. Supplementary
funding to Fraser Health Authority for an expansion of
cataract surgery services is the context for the analysis
reported in this paper. As the data were collected for the
service evaluation of cataract surgery outcomes, this
study did not require ethical review by the Fraser Health
Authority Research Ethics Board.
The primary study questions are:
1What level of visual impairment was seen in patients
scheduled for cataract surgery?
2What level of improvement in visual function was
seen following cataract surgery?
On the latter issue, most previous work, including the
RESIO study, assessed either the visual functioning gains
after first eye surgery only [11] or after second eye sur-
gery only [13,14]. The work reported here takes the view
that cataract surgery should be defined as treatment of
the person (i.e. surgery on both eyes) and not a single
eye, given that sight in both eyes is important for health-
related quality of life.
Recently, VF-14 thresholds for a minimal detectable
change (MDC) and a minimal clinically important differ-
ence (MCID) were established [15]. MDC is the thresh-
old for distinguishing between actual change and
measurement error, estimated to be 10.81 on the VF-14
scale [15,16]. MCID is the threshold that indicates the
minimum change in score necessary for a patient to ex-
perience a clinically important improvement, estimated
as 15.57 for VF-14 [15,16]. Given these new thresholds,
our third study question is:
3 Did gains in visual function following cataract surgery
reach the MDC and MCID thresholds, and what are
the implications of these thresholds for clinical
practice in Canada?Methods
Study design and sample
Data were collected on a population-based prospective
cohort of ophthalmology patients listed for cataract sur-
gery in the Fraser Health Authority in British Columbia
between April 1, 2009 and March 31, 2010. The study de-
sign was a non-experimental pre-post-test design. Data
were collected before surgery and at seven weeks post-
cataract surgery to allow pre-operative visual function
and visual acuity to be described and variation in patient
outcomes to be explored. Figure 1 illustrates the distribu-
tion of the patient sample from which the data for this
paper have been derived. Only 35 patients (8%) actively
refused to take part in the evaluation. Within the study
period, 87 patients received surgery on their first eye only
and 55 had cataracts removed from both eyes.
Measurements
At baseline, data were collected on:
 Visual function (VF-14) [17]
 Best corrected visual acuity (Snellen Fractions) [18]
 Clinical variables: glare, ocular comorbidities, eye
surgery (first, second or both eyes)
 Indications for surgery (i.e., ‘significant cataract’,
‘needs better vision’ and ‘other medical indication’)
 Age and sex
Based on clinical considerations regarding the degree
of severity of visual impairment, three Snellen visual
acuity categories were used to reflect the visual acuity
reported by the ophthalmologist: ≤0.1 (lowest acuity);
0.2 – 0.4; and ≥0.5 (highest acuity) [18].
At follow-up (seven weeks), data were collected on vis-
ual function using the VF-14.
The primary outcome measure for this analysis is the
VF-14, a valid and reliable 14-item instrument used to
assess functional impairment related to vision in both
eyes [17,19]. Each item has four possible responses. The
questionnaire asks about ability to perform activities of
daily living including day and night-time driving, reading
small print or traffic signs and engaging in recreational
activities. The instrument’s scale ranges from 0 (worst,
unable to do all activities) to 100 (best, able to all activ-
ities without difficulty).
Statistical analysis
Analysis for question 1 (What level of visual impairment
was seen pre-operatively in patients scheduled for cata-
ract surgery?)
All patients listed for their first cataract surgery were
grouped together into an ‘all first eye’ cohort (n = 142;
see Figure 1). This includes patients who only had one
surgery in the study period (n = 87) and those who had
Unable to participate (n=460): 
- Declined (n=35) 
- Surgery cancelled (n=7) 
- Non-responder (n=341) 
- Unable to complete survey due to language or 
comprehension difficulty (n=77) 
Cataract 
surgery on 




Patients who agreed to participate (n=360) 




















Total number of patients approached for inclusion in study (n=820) 
Figure 1 Flow of study subjects.
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dow (n = 55). For all variables collected at baseline, de-
scriptive statistics were calculated.
Analysis for question 2 (What level of improvement in
visual function was seen following cataract surgery?)
Given the focus on the person rather than the eye, this
analysis includes only patients who received surgery for
both their first and second eye within the study period
(‘both eyes’, n = 55). Descriptive statistics were calculated
for the post-operative VF-14, and for the change in VF-
14 scores (week 7 score minus baseline score).
Analysis for question 3 (Did gains in visual function
following cataract surgery reach the MDC and MCID
thresholds?)Estimates were made of the proportion of patients
achieving the respective MDC and MCID threshold
levels of 10.81 and 15.57. Given that this analysis is con-
cerned with the change in VF-14, the sample used for
this analysis includes only patients who received surgery
for both their first and second eye within our data col-
lection time frame (‘both eyes’, n = 55).
At follow-up, not all patients in the ‘both eyes’ cohort
had ‘corrected’ vision – some required new reading and/
or distance glasses but had not acquired them at follow-
up. A sub-group of the ‘both eyes’ cohort was established
comprising only those with corrected vision (n = 23).
The MDC and MCID thresholds were applied to this
sub-group.
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Sample
Table 1 details the characteristics of participants for both




‘Both Eyes’ (n = 55)
First Eye/Second Eye




Age 72.8 (8.1) 73.0 (7.2)
Female 86 (60.6) 36 (65.5)
Visual acuity
≥0.5 (20/40) 49 (34.5) 28 (50.9)/41 (74.5)
0.2-0.4 (20/100-20/50) 80 (56.3) 24 (43.6)/13 (23.6)
≥0.1 (20/200) 13 (9.2) 3 (5.5)/1 (1.8)
Glare
None 12 (8.6) 3 (5.5)/3 (5.5)
Mild 5 (3.6) 3 (5.5)/2 (3.6)
Moderate 105 (75.5) 36 (65.5)/45 (81.8)
Severe 17 (12.2) 13 (23.6)/5 (9.1)
Age Related Macular Degeneration
None 119 (84.4) 42 (76.4)
Mild 20 (14.2) 11 (20.0)
Moderate 2 (1.4) 2 (3.6)
Severe 0 (0) 0 (0)
Ocular Comorbidities
None 118 (83.7) 42 (77.8)/43 (79.6)
Mild 13 (9.2) 7 (13.0)/7 (13.0)
Moderate 9 (6.4) 4 (7.4)/2 (3.7)
Severe 1 (0.7) 1 (1.9)/2 (3.7)
Extent of Impairment in Visual Function
None 1 (0.7) 1 (1.8)/0 (0)
Mild 16 (11.3) 5 (9.1)/3 (5.5)
Moderate 123 (86.6) 47 (85.5)/52 (94.5)
Severe 2 (1.4) 2 (3.6)/0 (0)
Ability to Function Independently
Not threatened/no difficulties 15 (10.6) 4 (7.3)/3 (5.5)
Not threatened but more difficult 68 (47.9) 44 (80.0)/47 (85.5)
Threatened but not immediately 51 (35.9) 7 (12.7)/5 (9.1)
Immediately threatened or unable 8 (5.6) 0 (0)/0 (0)
Indications for first/second eye
Significant cataract 137 (100) 55 (100)/52 (98.1)
Driving 17 (12.4) 9 (16.4)/10 (18.9)
Needs better view 0 (0) 0 (0)/1 (1.9)
Other medical disease 2 (1.5) 1 (1.8)/1 (1.9)ranged in age from 45 to 94 years, with a mean age of
73, and the majority were female.
Baseline visual impairment levels
Baseline data on best corrected visual acuity for the ‘all
first eye’ group spanned the entire range with 34.5%
scoring 0.5 or better, 56.3% scoring between 0.2 and 0.4
and 90.8% scoring 0.2 or better (Table 1). The pre-
operative VF-14 scores for the ‘all first eye’ sample are
shown in Figure 2. The mean pre-operative VF-14 score
was 86.7 (median: 90.9; interquartile range: 14.6). A
highly skewed baseline VF-14 distribution is revealed
with the vast majority of patients having a score of 80 or
higher (on the 0–100 scale). For the ‘both eyes’ group,
most patients (74.5%) had better baseline visual acuity in
their second eye (Table 1).
In order to provide a reference point, comparison was
made of these new data with those reported by the
RESIO investigators a decade earlier (Figure 3). (Note,
the RESIO data are also ‘first eye only’.) The distribution
of pre-surgery VF-14 scores for the new cohort is further
right-skewed compared to RESIO, indicating even higher
levels of visual functioning pre-surgery.
Post-operative visual functioning, change in outcomes
and MCID/MDC
Figure 4 reports the post-operative VF-14 scores. Data
are presented for the ‘all first eyes’ and ‘both eyes’ groups.
 For the ‘all first eye’ group, the mean post-operative
VF-14 score was 92.0 (median: 96.8 interquartile
range: 12.5).
 For the ‘both eyes’ group, the mean post-operative
VF-14 score was 94.8 (median: 97.9, interquartile
range: 9.0).
The vast majority of all patients had a post-operative
score above 85. The ‘all first eye’ and ‘both eyes’ groups
differ at the top end of the scale: in excess of 60% of the
‘both eyes’ cohort report a score of 95 or higher, com-
pared to approximately 50% of the ‘all first eye’ patients.
The data highlight that patients in the ‘all first eye’ group
do not experience the full magnitude of benefit until
their second eye is completed, supporting a focus on
‘both eyes’ in looking at outcomes in this patient group.
The change in visual functioning (from baseline to
seven weeks post-surgery) is reported in Figure 5 and
Table 2. For the ‘both eyes’ group, the mean change in
VF-14 was 7.5 (standard deviation: 11.3). Despite this
average indicating a positive VF-14 change, 17.3% of
patients reported a decline in visual functioning post-
surgery, and a further 5.8% experienced no change. The
remainder, and the majority, of the patient cohort
(76.9%) experienced an improvement in visual function.
Figure 2 Pre-operative VF-14 for the Fraser Health ‘All First Eye’ cohort (n = 142).
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acuity (Table 2), a trend is evident: larger gains in visual
functioning were achieved by patients with poorer baseline
visual acuity. This is an unsurprising finding, given the
greater scope for improvement amongst those with poorer
functioning, but nevertheless important to document.
As indicated earlier, the MCID for the VF-14 is 15.57
and the MDC is 10.81 [14]. For individuals in the ‘both
eyes’ cohort, 23% achieved an improvement in visual
function that was at or beyond the MCID threshold and
35% saw an improvement beyond the MDC.
For the ‘corrected’ vision sub-group, improvements in
visual function beyond the MDC and MCID thresholds
were 26% and 39% respectively.
Discussion
Let us return to our primary study questions.Figure 3 Pre-operative VF-14 for the RESIO cohort (n = 2840) and Fras1What level of visual impairment was seen in patients
scheduled for cataract surgery?
The level of visual functioning pre-operatively is high,
with a mean VF-14 score of 86.7 and a highly skewed
distribution. The RESIO project, conducted over 10 years
ago, highlighted that the pre-operative visual function in
Canada was higher than that for other cohorts in the
United States, Denmark and Spain [20]. Despite this ini-
tial evidence that patients in Canada may be going for
surgery earlier than elsewhere, our new data highlight
that the distribution may have shifted even further to
the right, indicating even higher levels of visual func-
tioning pre-operatively.
2What level of improvement in visual function was
seen following cataract surgery?er Health ‘All First Eye’ cohort (n = 142).
Figure 4 Post-operative VF-14 (‘All First Eye’, n = 142; ‘Both Eyes’, n = 52).
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points on the VF-14 scale. However, approximately one
in five patients receiving cataract surgery recorded
poorer visual functioning after surgery, and a further one
in 15 appeared to experience no change. The variation in
gains is largely explained by baseline visual acuity: the
greatest improvements were seen in those with the poor-
est acuity levels. This is a finding well supported in the
literature [21]. Specifically, one recent study in the UK
demonstrated that if the average gain per patient in visual
functioning was 5.5 points on the VF-14 scale, 30% of
operations would be deemed inappropriate [12]. If aver-
age gain per patient in visual functioning was 12.2 points
on the VF-14 scale, 49% of operations would be deemed
inappropriate. Of note, in this example inappropriateness
was defined using threshold for different levels of change
in visual function. For example, with a threshold of 5.5
on the VF-14 scale, many patients got past this low
threshold and thus few were deemed inappropriate. In
contrast, with a threshold of 12.2, fewer patients got toFigure 5 Mean VF-14 Change (‘All First Eye’, n = 142; ‘Both Eyes’, n = 5this higher level and thus more were deemed inappropri-
ate. Further, they detailed that the method of determining
a clinically important difference strongly influenced the
percentage of operations deemed inappropriate [12]. In
the quest for the best clinical outcomes, which in turn
drives efficiency, it seems important to examine the
criteria used for assessing appropriateness of cataract
surgery [2-4].
3 Do gains in visual function following cataract surgery
reach the MDC and MCID thresholds, and what are
the implications of these thresholds for clinical
practice in Canada?
The concepts of MDC and MCID are important in
making judgments concerning value. We should expect
that health gains post intervention achieve at least the
MDC; if they do not then we are unable to distinguish
between actual change and measurement error. Our
hope, of course, is that the MCID threshold for2).
Table 2 Mean VF-14 change scores in ‘Both Eyes’ by
clinical indicators of severity
Baseline Characteristics VF-14
Mean Change (SD)
Total (n = 52) 7.5 (11.3)
Female (n = 34) 6.4 (12.6)
Male (n = 18) 9.7 (8.3)
Visual Acuity
≥0.5 (20/40) (n = 27) 4.2 (10.3)
0.2-0.4 (20/100-20/50) (n = 24) 11.5 (12.0)
≤0.1 (20/200) (n = 1) 8.9 (5.7)
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patients are routinely experiencing clinically important
improvements as a result of surgery. The disappointing
finding is that the majority of patients did not meet the
VF-14 thresholds of 10.81 and 15.57 for MDC and
MCID respectively. The most plausible hypothesis for
this finding is that we are not able to observe a MDC or
MCID in most patients because of their high pre-
operative visual functioning.
Providing refractive correction is necessary to mini-
mize visual impairment in cataract surgery patients [22].
In our sub-group analysis of patients who had experi-
enced vision correction post-surgery, the proportion of
patients reaching the MCID and MDC thresholds was
only slightly higher than in the overall ‘both eyes’ cohort.
Thus, the conclusion that the majority of patients do not
reach the thresholds is robust.
In considering the appropriate unit of analysis (i.e., eye
or person), we found that the gains in visual function
are greater when the analysis focused on those who
received cataract extractions in both eyes rather than
those who received the first eye only. Often vision is not
corrected with eye glasses until after the second eye is
completed. Thus, the magnitude of improvement after
the first cataract surgery will likely be less and so it
seems unfair to assess outcomes for partial procedures.
Moving forward, we suggest using ‘both eyes’ (i.e., the
person) for analyses of cataract procedures. The VF-14
was designed to be completed by the patient considering
their visual functioning with both eyes [18,23]. There-
fore, using the person as the unit of analysis aligns with
the original intention of the instrument. This recom-
mendation will impact future effectiveness and efficiency
estimates for cataract extraction.
Limitations of the VF-14
The primary limitation of this study may be the sole use
of the VF-14. Although the VF-14 was used due to its
widespread use in the literature to provide a basis for
comparison of our study findings, there is notableskepticism relating to the validity of the VF-14. Given
that safety and predictability of cataract surgery have
improved over the years, it is possible that the VF-14 is
out of date and that other newer instruments are demon-
strated as more responsive to cataract surgery [24]. A few
reasons why the VF-14 is one of the least responsive
instruments may be related to the structure of the ques-
tionnaire responses (i.e., not framed to encourage admis-
sion of disability) and the instrument noise [25,26].
Although the noise of the VF-14 can be improved
through Rasch analysis, we did not include that in this
analysis because it would then render it impossible to
make meaningful conclusions relating to MDC and
MCID values. Thus, our conclusions should be inter-
preted keeping the limitations of the VF-14 in mind.
This study was conducted as an evaluation and so data
were not collected on socio-economic status, other ac-
tivities of daily living and non-ophthalmologic co-mor-
bidities. The pre-operative visual acuity was collected
earlier, at the time that the patient was first scheduled
for surgery, than was visual function, which was col-
lected at the time of surgery. As a result, visual acuity
may decrease between the time of assessment and im-
mediately prior to surgery. The MDC and MCID ana-
lyses should be interpreted with caution, given that the
formulation of these thresholds is dependent on the vis-
ual functioning of the population used. Finally, the ideal
would be to map longitudinal outcome trajectories to as-
sess the potential longer-term benefits associated with
early cataract surgery.
Conclusions
Some patients going forward for cataract surgery have
very high levels of visual function. The consequence of
this, unsurprisingly, is that clinically important improve-
ments in visual function are not being seen in all
patients and so the full value from the intervention is
not being gained. This observation speaks to the poten-
tial benefits, from a clinical program management per-
spective, of routine collection and evaluation of
thresholds and outcomes data for surgical procedures,
such as cataract surgery. Further, future research should
continue to focus analyses on the person (i.e., ‘both eyes’)
and consider the longer-term trajectory of benefits from
cataract surgery.
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